Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-MD1003 in Healthy Male Subjects
Clinical trial NCT04223232 · COMPLETED
Trial details
- NCT number
- NCT04223232
- Sponsor
- MedDay Pharmaceuticals SA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-10
- Primary completion
- 2020-01-22
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.